Showing results (101-110 of 289) with videos related to

Sort By:
Pageof 29
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
Novel concepts for initiating multitargeted kinase inhibitors in radioactive iodine refractory differentiated thyroid cancerR Michael Tuttle, Marcia S Brose, Enrique Grande, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2010
Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patternsMichael Rivera, Julio Ricarte-Filho, Jeff Knauf, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinomaRichard J Robbins, Shefali Srivastava, Ashok Shaha, et al.
Thyroid : Official Journal of the American Thyroid Association|July 2, 2015
Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of RecurrenceFabián Pitoia, Fernando Jerkovich, Carolina Urciuoli, et al.
Thyroid : Official Journal of the American Thyroid Association|September 24, 2010
Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extensionMichael Rivera, Julio Ricarte-Filho, Robert Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association|March 2, 2010
Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy functionR Michael Tuttle, Norma Lopez, Rebecca Leboeuf, et al.
European Endocrinology|April 11, 2018
Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive IodineShrujal S Baxi, Rachel Kurtzman, Anne Eaton, et al.
Pageof 29